MMR-deficient Tumors
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors (NCT02646748) | Incyte Corporation | 2016-01-25 |
Track MMR-deficient Tumors automatically
Every clearance here is in the API, with alerts when new ones post.